Back to Directory
OvartiX
East of England
Founded 2024
Human ovarian cell models and multi-omics drug discovery
OvartiX is a Cambridge biotechnology company developing drug-discovery tools and therapeutic programmes for ovarian and reproductive health.
Its platform combines human multi-omics datasets, machine learning and engineered two- and three-dimensional ovarian cell models to identify and validate disease targets.
Founded in 2024, the company is investigating opportunities related to menopause, polycystic ovary syndrome and other female reproductive conditions. Its research is at an early stage, with no clinical-stage treatments independently established.